(15558808), E. R. J., (15558811), R. J. D., (15558814), D. E. S., (15558817), M. L. P., (15558820), A. M., (15558823), S. Y., . . . (15122218), M. D. D. (2025). Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
Cita Chicago (17th ed.)(15558808), Evangeline R. Jackson, et al. Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma. 2025.
Cita MLA (9th ed.)(15558808), Evangeline R. Jackson, et al. Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma. 2025.
Atenció: Aquestes cites poden no estar 100% correctes.